S. Daffis

发表

Mastomys natalensis and Lassa Fever, West Africa

S. Günther, J. T. ter Meulen, É. Lecompte, 2006, Emerging infectious diseases.

S. Günther, É. Lecompte, B. Soropogui, 2006 .

Fluctuation of abundance and Lassa virus prevalence in Mastomys natalensis in Guinea, West Africa.

J. T. ter Meulen, É. Lecompte, B. Soropogui, 2007, Vector borne and zoonotic diseases.

Anti-HBV response to toll-like receptor 7 agonist GS-9620 is associated with intrahepatic aggregates of T cells and B cells.

I. Mikaelian, R. Lanford, D. French, 2017, Journal of hepatology.

Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B.

R. Halcomb, Peng Yue, B. Tennant, 2015, Journal of hepatology.

The role of myristoylation in the membrane association of the Lassa virus matrix protein Z

W. Garten, T. Strecker, A. Maisa, 2006, Virology Journal.

The Innate Immune Adaptor Molecule MyD88 Restricts West Nile Virus Replication and Spread in Neurons of the Central Nervous System

M. Diamond, R. Klein, M. Gale, 2010, Journal of Virology.

Reproductive characteristics of Mastomys natalensis and Lassa virus prevalence in Guinea, West Africa.

J. T. ter Meulen, É. Lecompte, E. Fichet-Calvet, 2008, Vector borne and zoonotic diseases.

Spatial distribution of commensal rodents in regions with high and low Lassa fever prevalence in Guinea

É. Lecompte, C. Denys, B. Soropogui, 2005 .

Toll-Like Receptor 3 Has a Protective Role against West Nile Virus Infection (cid:1)

M. Diamond, M. Gale, M. Suthar, 2008 .

Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism.

F. Zoulim, E. Salas, S. Balsitis, 2017, Journal of hepatology.

P0535 : Direct antiviral effects of various pattern recognition receptor (PRR) agonists in HBV-replicating hepatocytes

F. Zoulim, D. Durantel, S. Fletcher, 2015 .

Activation of the cytokine network and unfavorable outcome in patients with yellow fever.

H. Zeller, W. Preiser, M. Niedrig, 2004, The Journal of infectious diseases.

West Nile Virus Noncoding Subgenomic RNA Contributes to Viral Evasion of the Type I Interferon-Mediated Antiviral Response

Daphne A. Cooper, S. Akira, M. Diamond, 2012, Journal of Virology.

The Naturally Attenuated Kunjin Strain of West Nile Virus Shows Enhanced Sensitivity to the Host Type I Interferon Response

M. Diamond, W. Liu, Helen M. Lazear, 2011, Journal of Virology.

Discovery of GS-9688 (Selgantolimod), as a Potent and Selective Oral Toll-like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B.

Helen Yu, R. Mackman, T. Appleby, 2020, Journal of medicinal chemistry.

Therapeutic Potential of TLR8 Agonist GS‐9688 (Selgantolimod) in Chronic Hepatitis B: Remodeling of Antiviral and Regulatory Mediators

S. Lehar, W. Rosenberg, S. Fletcher, 2020, Hepatology.

Toll‐Like Receptor 8 Agonist GS‐9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B

R. Mackman, S. Balsitis, W. Delaney, 2020, Hepatology.

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes

M. Ait-goughoulte, F. Zoulim, F. Cosset, 2018, Scientific Reports.

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes

M. Ait-goughoulte, F. Zoulim, F. Cosset, 2018, Scientific Reports.

2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members

Hongping Dong, Michael S. Diamond, Pei-Yong Shi, 2010, Nature.

Induction of IFN-β and the Innate Antiviral Response in Myeloid Cells Occurs through an IPS-1-Dependent Signal That Does Not Require IRF-3 and IRF-7

M. Diamond, M. Gale, Kristy J. Szretter, 2009, PLoS pathogens.

Interferon Regulatory Factor-1 (IRF-1) Shapes Both Innate and CD8+ T Cell Immune Responses against West Nile Virus Infection

M. Diamond, M. Gale, M. Suthar, 2011, PLoS pathogens.

Genetic identification of Kodoko virus, a novel arenavirus of the African pigmy mouse (Mus Nannomys minutoides) in West Africa.

R. Charrel, J. Meulen, J. T. ter Meulen, 2007, Virology.

Cell-Specific IRF-3 Responses Protect against West Nile Virus Infection by Interferon-Dependent and -Independent Mechanisms

M. Diamond, M. Gale, Melanie A. Samuel, 2007, PLoS pathogens.

Measure and Countermeasure: Type I IFN (IFN-α/β) Antiviral Response against West Nile Virus

M. Diamond, M. Suthar, S. Daffis, 2009, Journal of Innate Immunity.

Toll-Like Receptor 3 Has a Protective Role against West Nile Virus Infection

Michael Gale, Michael S. Diamond, M. Diamond, 2008, Journal of Virology.

The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection

E. Salas, S. Fletcher, G. Cheng, 2017, PloS one.

Interferon Regulatory Factor IRF-7 Induces the Antiviral Alpha Interferon Response and Protects against Lethal West Nile Virus Infection

M. Diamond, M. Gale, M. Suthar, 2008, Journal of Virology.

A Temporal Role Of Type I Interferon Signaling in CD8+ T Cell Maturation during Acute West Nile Virus Infection

M. Diamond, R. Schreiber, K. Murphy, 2011, PLoS pathogens.

Safety, Pharmacokinetics and Pharmacodynamics of Selgantolimod, an Oral Toll-Like Receptor 8 Agonist: A Phase Ia Study in Healthy Subjects

R. Mackman, A. Gaggar, S. Fletcher, 2020, Antiviral therapy.

Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8â†o T cell immune responses against West Nile virus infection

M. Diamond, M. Gale, M. Suthar, 2022 .

Interferon regulatory factor-1 ( IRF-1 ) shapes both innate and CD 8 + T cell immune responses against West Nile virus infection

M. Diamond, M. Gale, M. Suthar, 2016 .

Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus Envelope.

G. Gao, H. Klenk, J. Qi, 2019, Cell reports.

Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants.

H. Klenk, R. Kontermann, H. Zeller, 2005, Virology.

IPS-1 Is Essential for the Control of West Nile Virus Infection and Immunity

Michael Gale, Michael S. Diamond, Sunil Thomas, 2010, PLoS pathogens.

Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro

M. Massari, G. Pedrazzi, P. Lampertico, 2023, Gut.

Alternating arenavirus vector immunization generates robust polyfunctional genotype cross-reactive HBV-specific CD8 T cell responses and high anti-HBs titers.

S. Balsitis, S. Fletcher, H. Lauterbach, 2023, Journal of Infectious Diseases.

TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism

B. Testoni, S. Daffis, A. Diederichs, 2024, Gut.